Table 2.
Gene | Polymorphism | Cases | Controls | Ethnicity | Comment | P-value | Odds ratio | References |
---|---|---|---|---|---|---|---|---|
KCNE1 minK | 38G | 331 | 441 | Caucasian | 0.004 | 1.73 | 32 | |
KCNE1 minK | 38G | 108 | 108 | Asian | 0.024 | 1.80 | 34 | |
KCNE5 | 97T | 158 | 96 | Caucasian | 0.007 | 0.52 | 35 | |
KCNH2 | K897T | 1207 | 2475 | Caucasian | 0.00033 | 1.25 | 33 | |
GNB3 | C825T | 291 | 292 | Caucasian | 0.02 | 0.46 | 36 | |
eNOS | 2786C | 331 | 441 | Caucasian | 0.01 | 1.50 | 32 | |
eNOS | G894T | 51 | 289 | Caucasian | HF patients | 0.001 | 3.2 | 127 |
SCN5A | H558R | 157 | 314 | Caucasian | 0.002 | 1.6 | 31 | |
GJA5 | –44AA/+71GG | 173 | 232 | Asian | <0.006 | 1.514 | 37 | |
AGT | M235T | 250 | 250 | Asian | <0.001 | 2.5 | 39 | |
AGT | G-6A | 250 | 250 | Asian | 0.005 | 3.3 | 39 | |
AGT | G-217A | 250 | 250 | Asian | 0.002 | 2.0 | 39 | |
AGT | T174M | 968 | 8267 | Caucasian | 0.05 | 1.2 | 126 | |
AGT | 20C/C | 968 | 8267 | Caucasian | 0.01 | 1.5 | 126 | |
ACE | D/D | 51 | 289 | Caucasian | HF patients | 0.016 | 1.5 | 127 |
ACE | D/D | 404 | 520 | Caucasian | <0.001 | 1.89 | 128 | |
MMP2 | C1306T | 196 | 873 | Asian | 1.26 × 10−2 | 8.1 | 129 | |
IL10 | A-592C | 196 | 873 | Asian | 3.7 × 10−3 | 0.32 | 129 | |
IL6 | G-174C | 26 | 84 | Caucasian | Post-operative AF (after CABG) | <0.001 | 3.25 | 130 |
SLN | C-65G | 147 | 92 | Caucasian | 0.011 | 1.98 | 124 |
ACE, angiotensin-converting enzyme; AGT, angiotensinogen; CABG, coronary artery bypass graft surgery; eNOS, endothelial nitric oxide synthase 3; GNB3, guanine nucleotide-binding protein; GJA5, connexin 40; HF, heart failure; IL6, interleukin 6; IL10, interleukin 10; MMP, matrix metalloproteinase; SLN, sarcolipin gene.